Published in J Allergy Clin Immunol on June 09, 2006
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis | NCT03397979
Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol (2008) 2.11
Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol (2007) 1.85
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med (2009) 1.83
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol (2010) 1.77
An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol (2010) 1.73
The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res (2011) 1.69
"Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol (2008) 1.64
Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol (2009) 1.52
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol (2009) 1.43
Cystatins in immune system. J Cancer (2012) 1.22
Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol (2009) 1.22
pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol (2009) 1.13
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res (2012) 1.11
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol (2012) 1.08
The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol (2014) 1.06
Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol (2009) 1.04
Specific immunotherapy in atopic dermatitis. Allergy Asthma Immunol Res (2014) 1.01
Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis. Ann Dermatol (2010) 1.00
Allergy and the skin. Clin Exp Immunol (2008) 1.00
Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children. Eur J Clin Microbiol Infect Dis (2010) 0.98
The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am (2010) 0.98
Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion. Am J Hum Genet (2011) 0.98
Atopic dermatitis and disease severity are the main risk factors for food sensitization in exclusively breastfed infants. J Invest Dermatol (2013) 0.98
Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol (2009) 0.97
Cellular changes that accompany shedding of human corneocytes. J Invest Dermatol (2012) 0.97
Evidence that stress to the epidermal barrier influenced the development of pigmentation in humans. Pigment Cell Melanoma Res (2009) 0.96
Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun (2011) 0.94
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol (2011) 0.91
Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies. J Pediatr (2010) 0.90
Expression of epidermal CAMP changes in parallel with permeability barrier status. J Invest Dermatol (2011) 0.90
Barrier requirements as the evolutionary "driver" of epidermal pigmentation in humans. Am J Hum Biol (2010) 0.89
Comèl-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol (2009) 0.88
Skin barrier function. Curr Allergy Asthma Rep (2008) 0.88
House dust mite-related allergic diseases: role of skin prick test, atopy patch test, and RAST in the diagnosis of different manifestations of allergy. Eur J Pediatr (2009) 0.86
Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol (2014) 0.85
House dust mite extracts activate cultured human dermal endothelial cells to express adhesion molecules and secrete cytokines. J Med Entomol (2009) 0.83
Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation. Int J Radiat Oncol Biol Phys (2011) 0.83
Lipid abnormalities and lipid-based repair strategies in atopic dermatitis. Biochim Biophys Acta (2013) 0.82
Infant skin-cleansing product versus water: a pilot randomized, assessor-blinded controlled trial. BMC Pediatr (2011) 0.82
Inducible Expression of a Resistance-Nodulation-Division-Type Efflux Pump in Staphylococcus aureus Provides Resistance to Linoleic and Arachidonic Acids. J Bacteriol (2015) 0.82
Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation. J Invest Dermatol (2014) 0.82
Jaundice associated pruritis: a review of pathophysiology and treatment. World J Gastroenterol (2015) 0.81
HaCaT Keratinocytes and Primary Epidermal Keratinocytes Have Different Transcriptional Profiles of Cornified Envelope-Associated Genes to T Helper Cell Cytokines. Biomol Ther (Seoul) (2012) 0.81
Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease. Drug Discov Today Dis Mech (2013) 0.81
Cytokines and chemokines in irritant contact dermatitis. Mediators Inflamm (2013) 0.80
Immunomodulation of skin cytokine secretion by house dust mite extracts. Int Arch Allergy Immunol (2011) 0.80
Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis. Drug Discov Today Dis Mech (2008) 0.79
STUDY OF THE ROLE OF SERUM FOLIC ACID IN ATOPIC DERMATITIS: A CORRELATION WITH SERUM IgE AND DISEASE SEVERITY. Indian J Dermatol (2011) 0.79
Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care. Pediatr Dermatol (2016) 0.79
Animal models of skin disease for drug discovery. Expert Opin Drug Discov (2013) 0.79
Effect of stored product mite extracts on human dermal microvascular endothelial cells. J Med Entomol (2012) 0.79
Epidermal tight junctions in health and disease. Tissue Barriers (2015) 0.78
The Importance of Acidification in Atopic Eczema: An Underexplored Avenue for Treatment. J Clin Med (2015) 0.78
Genetic variation in the epidermal transglutaminase genes is not associated with atopic dermatitis. PLoS One (2012) 0.78
Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity. PLoS One (2011) 0.78
Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study. Clin Cosmet Investig Dermatol (2015) 0.77
Absorption of chemicals through compromised skin. Int Arch Occup Environ Health (2009) 0.77
7,3',4'-Trihydroxyisoflavone Ameliorates the Development of Dermatophagoides farinae-Induced Atopic Dermatitis in NC/Nga Mice. Evid Based Complement Alternat Med (2013) 0.77
Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis. J Vet Sci (2013) 0.77
Prevention of atopic dermatitis. F1000 Med Rep (2012) 0.76
Association between autoimmune reactions and severity of atopic dermatitis in children with herpes virus infection. World Allergy Organ J (2013) 0.76
Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis. J Vet Sci (2012) 0.76
Skin Barrier Recovery by Protease-Activated Receptor-2 Antagonist Lobaric Acid. Biomol Ther (Seoul) (2016) 0.75
Cervicofacial Botryomycosis: Is Atopic Dermatitis a Predisposing Factor? Dermatopathology (Basel) (2014) 0.75
An mTORC1/AKT1/Cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in Atopic Dermatitis. J Allergy Clin Immunol (2016) 0.75
Effect of prolactin-induced protein on human skin: new insight into the digestive action of this aspartic peptidase on the stratum corneum and its induction of keratinocyte proliferation. J Invest Dermatol (2014) 0.75
IL-1β-Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted Proteases Is Mediated by Human β-Defensin 2. J Invest Dermatol (2016) 0.75
Current Understanding in Pathogenesis of Atopic Dermatitis. Indian J Dermatol (2016) 0.75
Colonization by S. aureus increases the EASI and the number of appointments by patients with atopic dermatitis: cohort with 93 patients. An Bras Dermatol (2013) 0.75
Tacrolimus ointment in the management of atopic dermatitis. Clin Cosmet Investig Dermatol (2009) 0.75
Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol (2016) 0.75
From morphology to biochemical state - intravital multiphoton fluorescence lifetime imaging of inflamed human skin. Sci Rep (2016) 0.75
Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry. J Allergy Clin Immunol (2016) 0.75
Gene-Environment Interactions-What Can These Tell Us about the Relationship between Asthma and Allergy? Front Pediatr (2017) 0.75
Atopic Dermatitis Studies through In Vitro Models. Front Med (Lausanne) (2017) 0.75
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol (2009) 2.43
Cytokine gene polymorphisms in heavy drinkers with and without decompensated liver disease: a case-control study. Am J Gastroenterol (2008) 2.00
Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol (2004) 1.87
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet (2006) 1.74
Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum (2008) 1.73
Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial. Br J Dermatol (2011) 1.63
A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics (2002) 1.58
Age-related loss of CpG methylation in the tumour necrosis factor promoter. Cytokine (2011) 1.58
The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet (2004) 1.24
C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine (2002) 1.17
Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: a systematic review and meta-analysis. J Periodontol (2012) 1.17
Environmental risk factors in congenital malformations of the eye. Ann Trop Paediatr (2002) 1.14
Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine (2006) 1.06
IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet (2008) 1.06
Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res (2003) 1.05
Detection of PrPCWD in feces from naturally exposed Rocky Mountain elk (Cervus elaphus nelsoni) using protein misfolding cyclic amplification. J Wildl Dis (2012) 1.01
Incunabular immunological events in prion trafficking. Sci Rep (2012) 0.93
Eye birth defects in humans may be caused by a recessively-inherited genetic predisposition to the effects of maternal vitamin A deficiency during pregnancy. Med Sci Monit (2003) 0.92
The activation of the retinoic acid response element is inhibited in an animal model of congenital diaphragmatic hernia. Biol Neonate (2003) 0.90
Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise. J Physiol (2004) 0.90
Genetic depletion of complement receptors CD21/35 prevents terminal prion disease in a mouse model of chronic wasting disease. J Immunol (2012) 0.90
Human interleukin-1 alpha gene expression is regulated by Sp1 and a transcriptional repressor. Cytokine (2005) 0.87
Single-point haplotype scores telomeric to human leukocyte antigen-C give a high susceptibility major histocompatibility complex haplotype for psoriasis in a Caucasian population. J Invest Dermatol (2005) 0.86
Malignant melanoma of the rectum: a case report. J Med Case Rep (2009) 0.84
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis. Pharmacogenet Genomics (2014) 0.84
The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum Immunol (2006) 0.84
Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med (2003) 0.83
HLA-C, CSTA and DS12346 susceptibility alleles confer over 100-fold increased risk of developing psoriasis: evidence of gene interaction. J Hum Genet (2011) 0.82
Complement protein C3 exacerbates prion disease in a mouse model of chronic wasting disease. Int Immunol (2013) 0.82
Genome-wide studies of psoriasis susceptibility loci: a review. J Dermatol Sci (2004) 0.80
IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implants Res (2003) 0.80
Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial. Dermatology (2010) 0.80
Genetic variations and inflammation: a practical nutrigenomics opportunity. Nutrition (2004) 0.80
Antioxidant status of the rat nasal cavity. Free Radic Biol Med (2003) 0.79
Olfactory repeated discrimination reversal in rats: effects of chlordiazepoxide, dizocilpine, and morphine. Behav Neurosci (2006) 0.79
Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss. Arch Dermatol Res (2013) 0.78
Predisposition to sensitive skin and atopic eczema. Community Pract (2005) 0.78
Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. Eur J Hum Genet (2008) 0.78
Identification of known and novel genes whose expression is regulated by endogenous retinoic acid during early embryonic development of the mouse. Mech Dev (2002) 0.77
CLN6 p.I154del mutation causing late infantile neuronal ceroid lipofuscinosis in a large consanguineous Moroccan family. Indian J Pediatr (2012) 0.77
Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss. J Dermatol Sci (2013) 0.77
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis. Arthritis Res Ther (2014) 0.77
Dopa oxidase activity in the hair, skin and ocular melanocytes is increased in the presence of stressed fibroblasts. Exp Dermatol (2005) 0.77
Selected variants of the melanocortin 4 receptor gene (MC4R) do not confer susceptibility to female pattern hair loss. Arch Dermatol Res (2012) 0.76
Counterpoint: Risk factors, including genetic information, add value in stratifying patients for optimal preventive dental care. J Am Dent Assoc (2015) 0.76
Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: no association with female pattern hair loss identified. Exp Dermatol (2012) 0.76
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors. Pharmacogenomics (2015) 0.76
In vitro effects of adriamycin: a dose-response study. Pediatr Surg Int (2007) 0.75
New insights into induction of early-stage neovascularization in an improved tissue-engineered model of psoriasis. J Tissue Eng Regen Med (2010) 0.75
The Identity-Location Binding Problem. J Vis (2015) 0.75
Patterns of expression of retinoic acid receptor beta 2 (RAR-beta2)-LacZ reporter gene in the embryonic foregut. Pediatr Surg Int (2007) 0.75
182 Ultra-Early (<12 Hours) Decompression Improves Recovery After Spinal Cord Injury Compared to Early (12-24 Hours) Decompression. Neurosurgery (2016) 0.75
The 3'-UTR AACCins5874 in the stratum corneum chymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis; causes an increased mRNA expression without altering its stability. J Dermatol Sci (2010) 0.75
Quo vadis: what is the future of periodontics? How will we get there? Periodontol 2000 (2017) 0.75